The ClassIDM solution is an integrated system enabling T2D patients to better manage their disease with the support of a data collection and processing ecosystem, a data visualisation platform and a portal for clinicians. The aim of the project is to show the effectiveness of the solution, through studies that provide patients with prototype smart devices that capture treatment and daily activity data. Patient data will be transferred to the cloud for processing, and then shared back to the patients and their care givers via insightful, real-time dashboards that can suggest adjustments in the patients’ behaviour and treatment.
Based on contextual research, the solution will be tailored to fit specific population needs. EIT Health supports the partnership in conducting component solution refinement, designing the study and complying with mandatory regulations regarding evaluation within multistep clinical studies.
Clinical studies will be rolled out in France and Germany, to assess impact in two different healthcare environments. The results will be scalable to other populations across the EU.